Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4364436 | 1.00 | MAOB (0.48) | MAOBHTR1AKMT2AZDHHC2MEN1 | |
| SCHEMBL27987849 | 0.98 | MAOB (0.47) | MAOBHTR1AKMT2AZDHHC2MEN1 | |
| SCHEMBL20565176 | 0.90 | MAOB (0.54) | MAOBHTR1AKMT2AZDHHC2MEN1 | |
| SCHEMBL17138211 | 0.87 | KMT2A (0.47) | MAOBHTR1AKMT2AMEN1KDM4E | |
| SCHEMBL17138213 | 0.87 | KMT2A (0.47) | MAOBHTR1AKMT2AMEN1KDM4E | |
| SCHEMBL574099 | 0.86 | KMT2A (0.50) | MAOBHTR1AKMT2AZDHHC2MEN1 | |
| SCHEMBL574100 | 0.86 | KMT2A (0.50) | MAOBHTR1AKMT2AZDHHC2MEN1 | |
| SCHEMBL11212354 | 0.84 | MAOB (0.50) | MAOBHTR1AKMT2AZDHHC2MEN1 | |
| SCHEMBL11212343 | 0.84 | MAOB (0.50) | MAOBHTR1AKMT2AZDHHC2MEN1 | |
| SCHEMBL7100110 | 0.84 | HSD17B10 (0.50) | KMT2AMEN1HPGDHSD17B10HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 16032 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230014425-A1 | PHENYLEPHRINE HYDROCHLORIDE READY-TO-USE SOLUTION | Hikma Pharmaceuticals International Limited | 2023-01-19 | — | — | US | claimed |
| US-20220023201-A1 | PHENYLEPHRINE HYDROCHLORIDE READY-TO-USE SOLUTION | HIKMA PHARMACEUTICALS USA INC. | 2022-01-27 | — | — | US | claimed |
| EP-3474849-A1 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DIABETES | The Broad Institute, Inc. (US) | 2019-05-01 | — | — | EP | claimed |
| EP-3137488-B1 | PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CELL-TARGETING MOLECULES COMPRISING THE SAME | MOLECULAR TEMPLATES INC (US) | 2019-01-02 | — | — | EP | claimed |
| US-9962369-B2 | Methods and compositions for transdermal delivery | SPRAYABLE HOLDINGS, INC. (US) | 2018-05-08 | — | — | US | claimed |
| US-9949952-B2 | Methods and compositions for transdermal delivery | SPRAYABLE HOLDINGS, INC. (US) | 2018-04-24 | — | — | US | claimed |
| WO-2018005445-A1 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DIABETES | THE BROAD INSTITUTE, INC. (US) | 2018-01-04 | — | — | WO | claimed |
| CN-106572986-A | Methods and compositions for transdermal delivery | 本杰明·M·余 | 2017-04-19 | — | — | CN | claimed |
| EP-3116489-A1 | METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY | Yu, Benjamin M. (US) | 2017-01-18 | — | — | EP | claimed |
| US-20160317435-A1 | METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF CAFFEINE IN THE FORM OF SOLUTIONS OR SUSPENSIONS | SPRAYABLE HOLDINGS, INC. | 2016-11-03 | — | — | US | claimed |
| WO-2014138708-A1 | METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF CAFFEINE IN THE FORMS OF SOLUTION OR SUSPENSION | YU BENJAMIN M (US) | 2014-09-12 | — | — | WO | claimed |
| US-20140256749-A1 | METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF CAFFEINE IN THE FORM OF SOLUTIONS OR SUSPENSIONS | SPRAYABLE HOLDINGS, INC. | 2014-09-11 | — | — | US | claimed |
| EP-1711207-A4 | INTERFERON ALPHA ANTIBODIES AND THEIR USES | MEDAREX INC (US) | 2008-05-07 | — | — | EP | claimed |
| EP-1761554-A2 | PEPTIDE ANTIBIOTICS AND METHODS FOR MAKING SAME | Biosource Pharm, Inc. (US) | 2007-03-14 | — | — | EP | claimed |
| EP-1212422-B1 | HUMAN CTLA-4 ANTIBODIES AND THEIR USES | MEDAREX INC (US) | 2007-02-21 | — | — | EP | claimed |
| EP-1711207-A2 | INTERFERON ALPHA ANTIBODIES AND THEIR USES | Medarex, Inc. (US) | 2006-10-18 | — | — | EP | claimed |
| WO-2006083317-A2 | PEPTIDE ANTIBIOTICS AND METHODS FOR MAKING SAME | BIOSOURCE PHARM, INC. (US) | 2006-08-10 | — | — | WO | claimed |
| WO-2005059106-A2 | INTERFERON ALPHA ANTIBODIES AND THEIR USES | MEDAREX, INC. (US) | 2005-06-30 | — | — | WO | claimed |
| EP-1295130-A2 | NIMR COMPOSITIONS AND THEIR METHODS OF USE | TRUSTEES OF TUFTS COLLEGE (US) | 2003-03-26 | — | — | EP | claimed |
| WO-2001070776-A2 | NIMR COMPOSITIONS AND THEIR METHODS OF USE | TRUSTEES OF TUFTS COLLEGE (US) | 2001-09-27 | — | — | WO | claimed |